V Square Quantitative Management LLC Purchases New Position in Cigna Group $CI

V Square Quantitative Management LLC purchased a new stake in shares of Cigna Group (NYSE:CIFree Report) during the fourth quarter, HoldingsChannel.com reports. The firm purchased 6,011 shares of the health services provider’s stock, valued at approximately $1,654,000.

A number of other hedge funds also recently bought and sold shares of CI. Capital Research Global Investors increased its holdings in Cigna Group by 140.2% during the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after purchasing an additional 1,855,897 shares during the period. Ameriprise Financial Inc. increased its holdings in Cigna Group by 54.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock valued at $615,781,000 after purchasing an additional 753,865 shares during the period. Balyasny Asset Management L.P. increased its holdings in Cigna Group by 1,057.2% during the 2nd quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock valued at $133,803,000 after purchasing an additional 369,775 shares during the period. Man Group plc increased its holdings in Cigna Group by 215.5% during the 2nd quarter. Man Group plc now owns 532,183 shares of the health services provider’s stock valued at $175,929,000 after purchasing an additional 363,510 shares during the period. Finally, Dodge & Cox increased its holdings in Cigna Group by 4.0% during the 3rd quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock valued at $2,682,231,000 after purchasing an additional 354,615 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling

In other news, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Robert W. Baird cut their price objective on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research report on Thursday, December 11th. Truist Financial lifted their price objective on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Mizuho set a $325.00 price objective on Cigna Group in a research report on Friday, January 9th. Finally, Royal Bank Of Canada cut their price objective on Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a research report on Friday, February 6th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $333.11.

Read Our Latest Stock Analysis on CI

Cigna Group Stock Performance

Shares of CI opened at $277.52 on Thursday. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average price is $276.26 and its 200-day moving average price is $278.75. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The stock has a market cap of $73.13 billion, a P/E ratio of 12.51, a P/E/G ratio of 0.94 and a beta of 0.26.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. During the same period in the previous year, the firm posted $6.64 EPS. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities research analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th were given a $1.56 dividend. The ex-dividend date of this dividend was Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is presently 28.13%.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.